Dana-Farber Cancer Research, Teaching Affiliate, Harvard Medical School
World's First Antibody Targeting B7H7 Approved For Clinical Trial In The Us
Newly Approved Targeted Drug Makes 79% Of Patients' Tumours Disappear Altogether, This Type Of Blood Tumour Is Saved!
New Developments In Gastric Cancer Research: Keytruda In Combination With Chemotherapy Significantly Improves Survival In Patients With Advanced Disease!
Study Shows Drug Halves Recurrence Rate In Patients With Early-Stage EGFR-Mutated Lung Cancer!
NYU Langone Hospitals